Nexalin Technology, Inc.
General ticker "NXL" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $15.0M (TTM average)
Nexalin Technology, Inc. does not follow the US Stock Market performance with the rate: -15.9%.
Estimated limits based on current volatility of 6.2%: low 0.43$, high 0.48$
Factors to consider:
- Total employees count: 8 (-42.9%) as of 2025
- China accounted for 50.5% of revenue in the fiscal year ended 2024-12-31
- US accounted for 49.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Going concern doubt, Regulatory and compliance, Profitability failure, Clinical trial failure, Market acceptance
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.38$, 1.23$]
- 2026-12-31 to 2027-12-31 estimated range: [0.30$, 0.98$]
Financial Metrics affecting the NXL estimates:
- Positive: with PPE of -1.4 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Negative: negative Operating income
- Positive: Inventory ratio change, % of -20.50 <= -0.75
- Positive: Interest expense per share per price, % of 0 <= 0.01
- Positive: Shareholder equity ratio, % of 80.86 > 64.23
- Negative: negative Net income
Short-term NXL quotes
Long-term NXL plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.11MM | $0.17MM | $0.30MM |
| Operating Expenses | $5.81MM | $7.92MM | $8.69MM |
| Operating Income | $-5.70MM | $-7.75MM | $-8.39MM |
| Non-Operating Income | $1.05MM | $0.14MM | $0.17MM |
| Interest Expense | $0.04MM | $0.00MM | $0.00MM |
| R&D Expense | $1.92MM | $1.19MM | $1.08MM |
| Income(Loss) | $-4.65MM | $-7.61MM | $-8.22MM |
| Net Income(Loss)* | $-4.65MM | $-7.61MM | $-8.22MM |
| Stockholders Equity | $3.21MM | $3.68MM | $3.75MM |
| Inventory | $0.16MM | $0.17MM | $0.13MM |
| Assets | $3.63MM | $4.22MM | $4.64MM |
| Operating Cash Flow | $-3.84MM | $-3.94MM | $-4.96MM |
| Capital expenditure | $0.11MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $4.45MM | $-0.58MM | $-0.13MM |
| Financing Cash Flow | $-0.20MM | $4.52MM | $5.17MM |
| Earnings Per Share** | $-0.63 | $-0.83 | $-0.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.